The abstract is read at the publisher; the summary is JClub's.
In a single-tertiary-hospital cohort of 310 deceased glioblastoma patients, 22% (67/310) received potentially inappropriate care in the final 3 months, mainly driven by chemotherapy (58/67).
- Why it matters: Aggressive end-of-life management may be misaligned with palliative needs in glioblastoma, but population-level frequency and determinants of potentially inappropriate care remain unclear.
- What they did: Medical records from January 2015 to February 2026 were reviewed for patients who survived at least 3 months after diagnosis; potentially inappropriate care was defined by specified utilization indicators, and logistic regression tested associated factors.
- The result: Chemotherapy accounted for 87% of cases (58/67), with ≥2 hospital admissions (10/67) and in-hospital death (9/67) also present; younger age and unmethylated MGMT promoter status were linked to higher likelihood.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.